Financial Statements and Related Announcement::Auditor's Comments of Accounts

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
30-Sep-2024 22:52:43
Status
New
Announcement Sub Title
Auditor's Comments of Accounts
Announcement Reference
SG240930OTHRIOPA
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)

Please refer to the attachment.

This announcement has been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.

Additional Details

For Financial Period Ended
30/06/2024

Attachments

iX - FY2024 Auditors Report Announcement.pdf
Total size =1231K